BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBIO
3751
Crescent Biopharma
CBIO
$610M
| $23.5K | ﹤0.01% |
55
+17
| +45% | +$10.9K |
|
|
ACOR
3752
DELISTED
Acorda Therapeutics
ACOR
| $23.5K | ﹤0.01% |
68
+18
| +36% | +$9.79K |
|
3753
Chemung Financial Corp
CHMG
$401M
| $23.3K | ﹤0.01% |
555
+29
| +6% | +$1.27K |
|
3754
Donegal Group Class A
DGICA
$692M
| $23.3K | ﹤0.01% |
1,586
-43
| -3% | -$626 |
|
3755
Lexicon Pharmaceuticals
LXRX
$1.05B
| $23.2K | ﹤0.01% |
7,714
+2,021
| +35% | +$6.26K |
|
3756
SandRidge Energy
SD
$529M
| $23.2K | ﹤0.01% |
4,938
-2,248
| -31% | -$12.9K |
|
3757
Forum Energy Technologies
FET
$932M
| $23.1K | ﹤0.01% |
747
+54
| +8% | +$2.22K |
|
3758
Protagonist Therapeutics
PTGX
$9.84B
| $23K | ﹤0.01% |
1,916
+1,622
| +552% | +$20.4K |
|
3759
IDT Corp
IDT
$1.63B
| $22.8K | ﹤0.01% |
2,169
+1,865
| +613% | +$18.6K |
|
|
FCCY
3760
DELISTED
1st Constitution Bancorp
FCCY
| $22.8K | ﹤0.01% |
1,218
+13
| +1% | +$232 |
|
|
UBFO
3761
DELISTED
United Security Bancshares
UBFO
| $22.8K | ﹤0.01% |
2,169
+46
| +2% | +$488 |
|
|
MGI
3762
DELISTED
MoneyGram International, Inc. New
MGI
| $22.8K | ﹤0.01% |
5,721
| – | – |
|
3763
Crawford & Co Class A
CRD.A
$627M
| $22.7K | ﹤0.01% |
2,089
+1,878
| +890% | +$19.3K |
|
3764
Mid Penn Bancorp
MPB
$969M
| $22.6K | ﹤0.01% |
881
+7
| +0.8% | +$175 |
|
3765
Peoples Bancorp of North Carolina
PEBK
$239M
| $22.6K | ﹤0.01% |
759
+20
| +3% | +$558 |
|
3766
Telkom Indonesia
TLK
$14.4B
| $22.5K | ﹤0.01% |
747
-613
| -45% | -$18.5K |
|
3767
International Money Express
IMXI
$343M
| $22.5K | ﹤0.01% |
1,636
+1,603
| +4,858% | +$22.4K |
|
|
AFI
3768
DELISTED
Armstrong Flooring, Inc.
AFI
| $22.5K | ﹤0.01% |
3,514
-1,121
| -24% | -$8.75K |
|
|
AFMD
3769
DELISTED
Affimed
AFMD
| $22.4K | ﹤0.01% |
761
+699
| +1,127% | +$20.8K |
|
3770
Weyco Group
WEYS
$446M
| $22.3K | ﹤0.01% |
987
+6
| +0.6% | +$150 |
|
|
PRTK
3771
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $22.3K | ﹤0.01% |
5,160
+1,584
| +44% | +$6.33K |
|
|
PKD
3772
DELISTED
Parker Drilling Company
PKD
| $22.3K | ﹤0.01% |
1,178
+729
| +162% | +$12.5K |
|
3773
Eastern Company
EML
$154M
| $22.2K | ﹤0.01% |
895
+12
| +1% | +$300 |
|
3774
Transcat
TRNS
$915M
| $22.2K | ﹤0.01% |
866
+848
| +4,711% | +$20K |
|
3775
Rockwell Medical
RMTI
$29.6M
| $22.1K | ﹤0.01% |
73
+21
| +40% | +$6.45K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.